Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Net Margin (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Net Margin for 16 consecutive years, with 23.94% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 1194.0% to 23.94% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 23.07% through Dec 2025, up 508.0% year-over-year, with the annual reading at 23.07% for FY2025, 508.0% up from the prior year.
  • Net Margin for Q4 2025 was 23.94% at Lemaitre Vascular, down from 28.44% in the prior quarter.
  • The five-year high for Net Margin was 28.44% in Q3 2025, with the low at 70.83% in Q4 2021.
  • Average Net Margin over 5 years is 12.75%, with a median of 16.34% recorded in 2021.
  • The sharpest move saw Net Margin crashed -8868bps in 2021, then surged 8160bps in 2022.
  • Over 5 years, Net Margin stood at 70.83% in 2021, then skyrocketed by 115bps to 10.77% in 2022, then surged by 35bps to 14.58% in 2023, then fell by -18bps to 12.0% in 2024, then skyrocketed by 99bps to 23.94% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 23.94%, 28.44%, and 21.45% for Q4 2025, Q3 2025, and Q2 2025 respectively.